Sign in
4

Changes in Ownership

HARROW, INC. Filed Acc 0001493152-24-007456

CEO of ImprimisRx acquired 30,000 shares (option exercise)

  • CEO of ImprimisRx acquired 12,616 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SAHAREK JOHN P. · CEO of ImprimisRx

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-20 Exercise or conversion : show line 1 in the form +30,000 $10.67 $320,100 262,419 D
2024-02-20 Exercise or conversion : show line 2 in the form −12,616 $10.67 $134,613 249,803 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-20 Exercise or conversion : show line 3 in the form RSU −30,000 0 D
Loading xslF345X05/ownership.xml…